abstract |
The present invention relates to 2-amino-1,3-thiazines of the general formula I ( I ) in which X is CR1R2, y is CR20R21 and Z is CR22R23 and R1, R2, R20, R21, R22 and R23 have the meanings specified in Claim 1, which are inhibitors of nitric oxide synthase, and their use for the treatment of diseases which are caused by an increased nitric oxide level. |